Clinical Trials Browser

SHR-1701 × Dermatologic × 1 year × Clear all

NCT07517653 2026-04-08

Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma

Phase 2 Not yet recruiting

Melanoma